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Purpose: To introduce a hybrid volumetric modulated arc therapy/intensity modulated radiation ther-
apy (VMAT/IMRT) optimization strategy called FusionArc that combines the delivery efficiency of
single-arc VMAT with the potentially desirable intensity modulation possible with IMRT.
Methods: A beamlet-based inverse planning system was enhanced to combine the advantages of
VMAT and IMRT into one comprehensive technique. In the hybrid strategy, baseline single-arc
VMAT plans are optimized and then the current cost function gradients with respect to the beam-
lets are used to define a metric for predicting which beam angles would benefit from further intensity
modulation. Beams with the highest metric values (called the gradient factor) are converted from
VMAT apertures to IMRT fluence, and the optimization proceeds with the mixed variable set until
convergence or until additional beams are selected for conversion. One phantom and two clinical
cases were used to validate the gradient factor and characterize the FusionArc strategy. Compar-
isons were made between standard IMRT, single-arc VMAT, and FusionArc plans with one to five
IMRT/hybrid beams.
Results: The gradient factor was found to be highly predictive of the VMAT angles that would benefit
plan quality the most from beam modulation. Over the three cases studied, a FusionArc plan with
three converted beams achieved superior dosimetric quality with reductions in final cost ranging
from 26.4% to 48.1% compared to single-arc VMAT. Additionally, the three beam FusionArc plans
required 22.4%–43.7% fewer MU/Gy than a seven beam IMRT plan. While the FusionArc plans
with five converted beams offer larger reductions in final cost—32.9%–55.2% compared to single-
arc VMAT—the decrease in MU/Gy compared to IMRT was noticeably smaller at 12.2%–18.5%,
when compared to IMRT.
Conclusions: A hybrid VMAT/IMRT strategy was implemented to find a high quality compro-
mise between gantry-angle and intensity-based degrees of freedom. This optimization method
will allow patients to be simultaneously planned for dosimetric quality and delivery efficiency
without switching between delivery techniques. Example phantom and clinical cases suggest
that the conversion of only three VMAT segments to modulated beams may result in a good
combination of quality and efficiency. © 2013 American Association of Physicists in Medicine.
[http://dx.doi.org/10.1118/1.4808153]
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I. INTRODUCTION
Intensity modulated radiation therapy (IMRT) and volumet-
ric modulated arc therapy (VMAT) are advanced radiotherapy
treatment delivery techniques that rely on increased degrees
of freedom during optimization. Both techniques create plans
that are generally considered to produce superior dose distri-
butions compared to conventional conformal techniques for
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moderate to complex treatment sites. IMRT takes advantage
of intensity modulation at favorable static beam angles, while
VMAT exploits the extra degrees of freedom provided by in-
creased angular sampling. While the latter may appear to in-
crease the overall possible plan quality, there are also restric-
tions based on the compatibility between adjacent apertures
and the speed of the dynamic delivery components. These
limitations make it less clear which technique is preferable
in different treatment situations.
A variety of recent publications have compared the mer-
its of the two techniques in various treatment sites.1–5 From
these studies, VMAT appears generally capable of produc-
ing plans that are dosimetrically equivalent to IMRT. VMAT
plans often require fewer monitor units and can also achieve
greater delivery efficiency. The improved delivery efficiency
of VMAT may lead to potential reductions in patient mo-
tion and the larger area apertures generally delivered by
VMAT suggest that VMAT dose distributions may be less im-
pacted by motion and interplay effects compared to complex
IMRT deliveries.6 However, the dosimetric quality of single-
arc VMAT plans for some complex treatment geometries has
failed to meet that of IMRT.1, 7, 8 For example, Popple et al.
reported that for prostate plans, VMAT results were compara-
ble to IMRT, but for other sites, such as head and neck, they
were unable to achieve equivalent plan quality with single arc
and in some cases, double arc VMAT.1 Most notably, they
saw improved target homogeneity with IMRT. Guckenberger
et al. have similarly shown that target volume complexity is
a factor in whether or not single arc VMAT is sufficient to
reach IMRT plan quality. They noted that multiple arc VMAT
can be applied at the cost of increased delivery time, mon-
itor units, and low dose spread.7 In a study by Tang et al.
multiple arc (IMAT), single arc (AMRT), and IMRT plans
were compared.9 All arc plans were developed with an in-
house algorithm which assumes a VMAT capable machine
with dose rate variation. The multiple arc plans achieved the
highest quality of the three, while the single arc plans com-
promised target coverage in order to spare normal tissues. It
was also noted that there are more deliverability constraints in
single arc plans compared to multiple arc plans, which in turn
can compromise the final results for single arc plans. As men-
tioned above, the use of additional VMAT arcs can lead to im-
proved quality over single-arc VMAT, making plans compara-
ble to IMRT.8–10 In certain situations, IMRT can still retain an
advantage (especially in target homogeneity) for cases with
multiple dose prescriptions due to the need for modulation
from selected beam angles. Thus, the improved delivery effi-
ciency of a single arc may be sacrificed for improved dosimet-
ric quality and potentially higher monitor units, or vice versa.
A system that can take advantage of the merits of both IMRT
and VMAT may provide the compromise between delivery
efficiency and plan quality that is needed to satisfy many clin-
ical situations.
Chan et al. found that optimizing a VMAT plan on top of
a baseline plan consisting of two manually placed 3D con-
formal (3DCRT) fields achieved higher dosimetric quality for
an assortment of nonsmall-cell lung cancer patients compared
to double-arc VMAT or 3DCRT alone with a slight increase
in delivery time compared to VMAT.11 Martin et al. have re-
cently compared a similar technique in esophageal carcinoma
by using four manually placed IMRT beams optimized on top
of a conformal arc with a user defined dose prescription.12
This technique was comparable to VMAT plans with one or
two arcs in some cases, but the lack of inverse planning for
the conformal arc, as well as the manual IMRT beam place-
ment, may have resulted in inferior coverage and an inability
to achieve some of the planning objectives.
BrainLAB (Feldkirchen, Germany) has recently intro-
duced HybridArc, a method which combines dynamic con-
formal arcs with IMRT. In this system, a user defined number
of IMRT beams are evenly spaced within a user defined con-
formal arc.13 Intensity values for the IMRT beams and confor-
mal arcs are chosen based on a user-defined variable, WTarc,
that limits the relative dose contribution from IMRT beams
to the total dose. However, this variable introduces the po-
tential for a wide range of plans with varying plan quality
based solely on the chosen values for WTarc.14 A recent pub-
lication on the use of HybridArc (Robar and Thomas) found
that increased conformity to the target was possible using 3–
15 IMRT beams for complex cranial cases, and up to five
beams for the prostate cases studied. HybridArc cranial plans
required an increase in MU compared to IMRT, while MU
were reduced for prostate cases.14
The current work describes a treatment planning strategy,
which we call FusionArc, that has been designed to combine
the merits of both VMAT and IMRT. The FusionArc strat-
egy was implemented in an inhouse optimization system. The
strategy begins with a single-arc VMAT plan as the baseline
plan and then converts selected VMAT apertures into IMRT
beams. The converted apertures are chosen by a metric we call
the gradient factor. The gradient factor is used to predict and
rank the VMAT apertures that will benefit most from modu-
lation and thus help to advantageously combine the two tech-
niques into one solution. In a hybrid situation, where the goal
would be to utilize the minimum number of IMRT beams nec-
essary, the placement of the IMRT beams is likely to be im-
portant. While there are usually intuitive directions that would
benefit from IMRT, the prediction of the best angle for mod-
ulation may become increasingly difficult as geometries be-
come more complex.
In this paper, we describe the FusionArc strategy, vali-
date the gradient factor metric, characterize the plan improve-
ment gained in several treatment sites with additional IMRT
beams, and compare the plan quality and efficiency of single-
arc VMAT, IMRT, and FusionArc hybrid plans.
II. METHODS AND MATERIALS
II.A. Hybrid VMAT/IMRT strategy and gradient
factor formulation
An inhouse developed beamlet-based optimization system,
UMOpt,15 was enhanced to include the simultaneous opti-
mization of both VMAT and IMRT, as shown in Fig. 1. The
process begins with the optimization of a single-arc VMAT
plan, using an arc approximated by many static beams and
predefined beamlets. All apertures are initialized to a uniform
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FIG. 1. Flowchart for FusionArc optimization strategy.
intensity and shaped to the target. Simulated annealing is used
to minimize a user-defined cost function designed with a va-
riety of custom planning objectives.16 The optimization pro-
cess proceeds for a user-defined number of iterations. Once
convergence is achieved, a gradient factor (GF) is calculated
for each aperture to predict the gantry angle that will give
the greatest reduction in the objective function value, or cost,
upon conversion to intensity modulation. The gradient factor
for aperture a, GFa, is calculated according to
GFa =
√∑N
i=1
(
g+i
)2 +∑M
j=1
(
g−j
)2
, (1)
where g+i is the cost function gradient with respect to beamlet
i,(∂F / ∂bi) (i.e., the partial derivative of the cost function with
respect to the intensity of beamlet i), and all beamlet intensi-
ties in set N are nonzero and have positive gradient values.
The variable g−j denotes the gradient with respect to beamlet
j where all beamlet gradient values in the set M have negative
values.
The first term in Eq. (1) represents the sum of squared
positive-valued gradients for beamlets that are active in the
current VMAT aperture. The positive-valued gradients repre-
sent beamlet intensities that would cause a reduction in the
final cost function value (in the local solution) if the beam-
let intensities were reduced. Since the inactive beamlets in
the aperture cannot be further reduced, they are excluded
from the first term in the gradient factor calculation. Simi-
larly, the second term in the GF formulation represents the
sum of squared negative-valued gradients for all beamlets in
the current VMAT aperture. The negative gradient values rep-
resent beamlet intensities that would result in the cost func-
tion decreasing if their values were increased. The gradient
factor is motivated by the local search method called steep-
est descent.17 In particular, the gradient factor for a beam can
be interpreted as the maximum rate of improvement in cost
function value as the current solution is modified in a feasi-
ble direction that corresponds to modulating that beam. Al-
though the gradient factor only considers the rate of improve-
ment rather than absolute improvement in objective function
value, we hypothesize that the gradient factor will be highly
correlated with the actual impact on the cost function value
after allowing modulation. Therefore, we expect that beam
delivery angles with a high GF will yield an increase in plan
quality, and thus a reduction in the final cost, upon conversion
to modulation.
Once a beam is chosen for conversion from aperture to
fluence optimization based on the GF, the optimization vari-
ables for that beam angle become beamlet intensities instead
of aperture intensities and shapes. All remaining VMAT aper-
tures continue to be available for further optimization along
with the IMRT, or hybrid, beams. Optimization proceeds for
a fixed number of iterations or until the change in the total cost
for a given number of iterations remains below a set thresh-
old. At that time, the process can continue by converting an-
other beam to IMRT using a new GF calculation or it can
be stopped. To convert an additional beam to fluence opti-
mization, the GF is recalculated based on the current solution
(VMAT with one IMRT beam). In this situation, we have ob-
served that the previously converted IMRT beam will have a
significantly lower GF than the VMAT apertures, as would be
expected. Preliminary investigation showed that plan quality
was improved by adding IMRT beams one at a time, but fur-
ther investigation into adding multiple beams at once may be
warranted to improve optimization efficiency.
II.B. Gradient factor validation
To test the correlation between the gradient factor and the
benefit of modulation, single-arc VMAT plans approximated
by 45 static beam angles were created and optimized sepa-
rately for three cases—one phantom and two clinical exam-
ples, which are discussed in more detail in Sec. II.C. Although
8◦ angular spacing is large for VMAT, this value was used for
the gradient factor validation since each beam was modulated
one by one. After convergence, each VMAT aperture was in-
dividually converted to an IMRT beam and optimization pro-
ceeded with one hybrid IMRT beam as shown in Fig. 2. The
final objective function value for each one beam hybrid plan
and the gradient factor associated with the modulated beam
were plotted as a function of VMAT gantry angle to deter-
mine if the gradient factor was able to predict which angles
benefited the most from modulation.
II.C. FusionArc plan comparisons
FusionArc comparisons were performed for three different
cases—the TG-119 prostate phantom18 and a pancreas and
brain case that had been previously treated with IMRT at our
institution. All patient plans were newly created under an in-
stitutional review board approved retrospective study. Plans
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FIG. 2. Flowchart for gradient factor validation strategy.
were evaluated quantitatively and qualitatively using a num-
ber of metrics including dose volume histograms (DVHs),
dose color wash images, and plots of plan quality (or final
cost) versus delivery efficiency, represented in monitor units
per Gray (MU/Gy). The geometries for each case are shown
in Fig. 3 and the planning goals are listed in Table I. The
planning goals for the prostate phantom case were obtained
from TG-119, and objective functions for the pancreas and
brain cases were based on current clinical practice at our
institution.
In order to characterize and show the feasibility of the Fu-
sionArc planning strategy, compared to conventional IMRT
and VMAT planning, each case was planned and optimized
with single-arc VMAT, standard IMRT, and FusionArc with
one to five hybrid beams. VMAT arcs were approximated
with 45 equally spaced static beam angles (8◦ angular spac-
ing) and the standard IMRT plans consisted of seven equally
spaced beams. Seven beams or less are typically used at our
institution for prostate, brain, and pancreas IMRT plans. All
apertures were shaped to the target and made use of a 5 mm
× 5 mm fluence map resolution. Limits for maximum beamlet
intensities were applied to prevent undesirably hot beamlets,
which can lead to increased MU with little to no improvement
in plan quality.19 This strategy is consistent with clinical prac-
tice at our institution. We followed the procedure outlined in
Coselmon et al.,19 using a maximum intensity ratio of 1.5–2.0
(using a standard seven beam plan).
III. RESULTS
A hybrid VMAT/IMRT treatment planning strategy was
successfully implemented within our inhouse treatment
planning system according to Fig. 1. As mentioned, the
FIG. 3. Case geometries: (a) TG-119 prostate phantom with PTV shown in pink, bladder in yellow, and rectum in brown. (b) Pancreas case with PTV in pink,
liver in brown, kidneys in yellow, and cord in green (GI structures not shown for clarity). (c) Brain case with PTV shown in pink, eyes in purple, left optic nerve
in yellow, optic chiasm in green, and normal brain in light blue.
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TABLE I. Planning objectives for TG-119 prostate, pancreas, and brain
cases.
TG119 Prostate inverse planning objectives
Structure Objectives
PTV 79.3 Gy ± 5% (Min ≥ 75.3 Gy; Max ≤ 83.3 Gy)
Bladder V75Gy < 10%
V70Gy < 30%
Rectum V75Gy < 10%
V70Gy < 30%
Normal tissue Minimize dose
Pancreas inverse planning objectives
Structure Objectives
PTV 55 Gy ± 5%
Cord D0.1cc ≤ 45 Gy
Liver D1cc ≤ 50 Gy
Kidneys D0.1 cc ≤18 Gy; (if cannot reach this for both kidneys, spare one)
Duodenum D2cc ≤ 52 Gy
Small bowel D2cc ≤ 52 Gy
Stomach D2cc ≤ 52 Gy
Normal tissue Minimize dose
Brain inverse planning objectives
Structure Objectives
PTV 60 Gy ± 5%
Chiasm D0.1cc ≤ 54 Gy
Eyes D0.1cc ≤ 45 Gy
Optic nerves D0.1cc ≤ 54 Gy
Normal tissue Minimize dose
Note: All normal structure doses were minimized after the listed planning objec-
tives were met.
strategy utilizes a gradient factor metric to predict which
VMAT beams will benefit most from added modulation.
Therefore, validation results for calculation of the gradient
factor are presented first, in order to characterize its use for
the FusionArc plan optimization strategy. Subsequently, the
results of utilizing the gradient factor to create comparisons
for three cases using standard IMRT, single-arc VMAT, and
FusionArc plans with one to five IMRT, or hybrid beams are
presented, in order to show the ability of this hybrid strategy
to provide a compromise between delivery efficiency and plan
quality.
III.A. Gradient factor validation
Using the strategy presented in Fig. 2, the three cases de-
scribed above were optimized to create baseline VMAT plans,
approximated by 45 static gantry angles. For each case, 45
one-beam hybrid plans were created by separately converting
each gantry angle to fluence. Each of the 45 one-beam hy-
brid plans was optimized using the same number of cycles
and iterations. The final cost, used here as a measure of plan
quality, was recorded for each trial and plotted against the GF
calculation, as seen in Figs. 4–6 (left). The validation tests il-
lustrate the ability of the GF to predict the beam directions
that will benefit most from modulation, where a high GF cor-
relates with a low final objective function value, and a low
GF is associated with a higher final cost. Figures 4–6 (right)
graph the change in cost versus the gradient factor to show
the quantitative correlation. The degree of linearity between
the gradient factor and associated plan cost upon conversion
to fluence suggests that the gradient factor calculation ade-
quately predicts beneficial beam angles to convert to fluence
optimization.
III.B. TG-119 prostate phantom case
The TG-119 prostate phantom case showed substantial re-
ductions in final cost and MU/Gy compared to the VMAT and
IMRT plans, respectively, with the addition of two to three hy-
brid beams as seen in Fig. 7. With only two hybrid beams, the
plan quality (inferred by the cost) is essentially equivalent to
that of the IMRT plan, but delivery efficiency is markedly re-
duced. Figure 8 shows the DVHs for four of the seven final
plans, demonstrating that the FusionArc plans are capable of
reducing bladder and rectum mean doses. FusionArc is also
capable of increasing PTV homogeneity compared to VMAT
to achieve coverage similar to IMRT. A three beam FusionArc
plan is capable of reducing MU/Gy by approximately 22.4%
compared to IMRT, while also reducing the final cost by about
38.3% compared to the VMAT plan. Meanwhile, a five beam
FusionArc plan can reduce the cost by 40.5% compared to
VMAT but only achieves a 12.2% reduction in MU/Gy com-
pared to IMRT.
III.C. Pancreas case
As seen in Fig. 9, the addition of only one IMRT beam
yields a reduction of approximately 63.2% MU/Gy compared
FIG. 4. Gradient validation with TG-119 prostate case. (Left) Gradient factor validation curve. (Right) Correlation between cost vs gradient factor for data on
left.
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FIG. 5. Gradient validation with pancreas case. (Left) Gradient factor validation curve. (Right) Correlation between cost vs gradient factor for data on left.
to IMRT, and a cost reduction of 19.5% compared to VMAT.
The three beam FusionArc plan results in a decrease of 41.3%
MU/Gy compared to IMRT and a 34.8% reduction in cost
compared to VMAT. The three, four, and five beam FusionArc
plans all showed improved plan quality (in terms of cost func-
tion value) in addition to reduced MU/Gy compared to IMRT.
Dose distributions, shown in Fig. 10, illustrate some of the
trade-offs made between the three techniques. For example,
due to the beam arrangement, the IMRT plan gives increased
dose to the stomach, but decreased dose to the small bowel
compared to the rotational techniques. As is commonly seen
with VMAT, there is an increase in the lower dose spread, but
a decrease in the moderate to high doses to normal tissues
compared to IMRT. The FusionArc plan has a slightly higher
peripheral hotspot in the liver, but improved target coverage
compared to both IMRT and VMAT plans.
III.D. Brain case
Compared to IMRT, the single-arc VMAT plans and
FusionArc plans are capable of reducing MU/Gy and there-
fore increasing delivery efficiency. Both the four beam hybrid
and the five beam hybrid plans were able to reduce the fi-
nal plan cost below that of the standard IMRT plan, while
maintaining lower MU/Gy. However, we recognize that the
three beam hybrid in this situation offers a better compromise
with a 26.4% reduction in cost compared to single-arc VMAT
and approximately 43% fewer MU/Gy when compared to
IMRT as seen in Fig. 11. Additionally, as seen in Fig. 12, the
FusionArc plans are capable of sparing the optic structures
more so than single-arc VMAT in order to meet the planning
objectives in Table I.
IV. DISCUSSION
IMRT and VMAT are two treatment modalities that offer
increased plan quality compared to 3D conformal plans by
relying on inverse planning and the many degrees of freedom
inherent in each planning technique. However, the trade-offs
between plan quality and delivery efficiency are not straight-
forward, and thus a synthesis of the two methods may provide
a reasonable compromise between the efficiency of VMAT
and the superior intensity modulation possible with IMRT.
In this work, a planning strategy called FusionArc has been
developed and tested on a phantom and two clinical cases
for two purposes: (1) to validate a GF calculation in order
to select the optimal beam angle to convert to fluence and (2)
to evaluate if the FusionArc optimization process offers im-
provements in plan quality over single-arc VMAT while of-
fering reasonable reductions in MU/Gy compared to IMRT.
The GF calculation was validated on three cases to quanti-
tatively and qualitatively show that a higher GF correlates
with a lower final cost when that beam is converted to flu-
ence, compared to the cost associated with converting a low-
valued GF beam to fluence. The results of this investigation
indicate that the gradient factor effectively predicts the VMAT
FIG. 6. Gradient validation with brain case. (Left) Gradient factor validation curve. (Right) Correlation between cost vs gradient factor for data on left.
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FIG. 7. Plan quality (cost) and efficiency (MU/Gy) for FusionArc plans of increasing modulation for the TG-119 prostate phantom.
apertures that would benefit plan quality most upon conver-
sion to modulation.
Each site comparison showed that FusionArc is capable of
increasing plan quality with the addition of more than one
hybrid beam, when compared to single-arc VMAT, while re-
ducing MU/Gy compared to IMRT. The benefit from the first
modulated beam shows the largest reduction in cost com-
pared to VMAT, but additional modulation with more con-
verted apertures also displays a marked decrease in plan cost.
In this study, the conversion of five VMAT apertures to flu-
ence offered final cost reductions ranging from 32.9% to
55.2% compared to VMAT. However, the associated decrease
in MU/Gy, 12.2%–18.5% when compared to IMRT, was dis-
tinctly smaller. For the cases presented here, it appears that
three beam FusionArc plans may offer a reasonable trade-off
between final plan cost and MU/Gy, with MU/Gy reductions
ranging from 22.4% to 43.7% compared to IMRT, and de-
creases in cost ranging from 26.4% to 48.1% compared to
single-arc VMAT plans. The increased monitor units required
with additional modulation suggest that clinical methods for
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FIG. 8. Dose volume histograms for the TG-119 prostate phantom with
seven beam IMRT, VMAT, three beam hybrid FusionArc, and five beam hy-
brid FusionArc plans.
determining the optimal compromise between quality and ef-
ficiency will need to be studied further. While a full investiga-
tion of the implications of increased MU/Gy is outside of the
scope of this work, it is important to note that reducing moni-
tor units and the associated leakage and whole body dose that
can accompany complex intensity modulated deliveries may
reduce the risk of secondary cancers associated with IMRT
delivery as well as reduce machine wear and tear and increase
department throughput.
Compared to current techniques for combining IMRT and
VMAT plans, FusionArc offers the flexibility of optimizing
VMAT apertures and IMRT beams concurrently, instead of
requiring the user to define constraints on dose contributions
from conformal arcs and IMRT beams. Additionally, the gra-
dient factor is fundamental in determining the optimal beam
angle to convert to fluence. HybridArc, which is geared to-
ward very conformal dose distributions for radiosurgery, re-
lies on fixed, equally spaced IMRT beams along a dynamic
arc.13, 14 In more complex geometries, this strategy may fail
to take into account geometrical considerations and could re-
sult in modulation at inappropriate angles.
A method proposed by Li and Xing20 similarly demon-
strates that additional modulation from “optimal” beam di-
rections improves plan quality compared to VMAT alone. In
their strategy, a large number of beam angles are used to in-
crease the angular sampling while also simplifying the in-
tensity modulation by eliminating the dispensable segments.
That method utilizes an IMRT delivery, which could be time
intensive, although some newer linear accelerator delivery
systems can deliver a high number of IMRT beams much
more efficiently than past designs.
It should be pointed out that inverse plan quality, whether
it be for IMRT, VMAT, or conformal methods, can be highly
dependent on the optimization algorithm, strategy, and cost
function chosen. This is especially true if the cost function is
not appropriate or the optimization algorithm allows the solu-
tion to fall into significant local minima. For example, IMRT
and VMAT will not attempt to reduce dose to uninvolved nor-
mal tissue without an explicit objective to do so. This specific
Medical Physics, Vol. 40, No. 7, July 2013
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FIG. 9. Plan quality (cost) and efficiency (MU/Gy) for FusionArc plans of increasing modulation for a pancreas patient.
FIG. 10. Dose colorwash comparisons for a pancreas case with axial (left) and sagittal (right) views. The PTV is outlined in dark blue, kidneys in yellow, spinal
cord in red, stomach in white, liver in brown, small bowel in green, and duodenum in light blue. (Top) Seven beam IMRT plan. (Middle) VMAT plan. (Bottom)
Three beam FusionArc plan.
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FIG. 11. Plan quality (cost) and efficiency (MU/Gy) for FusionArc plans of increasing modulation for a brain patient.
objective may be more important for VMAT due to the in-
crease in angular degrees of freedom.
Our work has been initially implemented into an inhouse
treatment planning system, so that we could hold as many
variables consistent between the plan comparisons as possi-
ble (optimization algorithm, intensity limits, fluence resolu-
tion, calculation resolution, cost function, etc.). We believe
it would be straightforward to implement the FusionArc strat-
egy within another planning system and reproduce the relative
results seen here. However, there will always be differences in
the absolute and relative plan quality due to the inherent dif-
ferences between inverse planning strategies, algorithms, and
cost functions throughout clinical and research optimization
systems.
Additional research work on the FusionArc method is war-
ranted in several areas. Most notable is further investigation
of the types of cases and geometries that will benefit most
from this hybrid strategy and if multiple arcs offer added
benefits over single-arc FusionArc plans. We also believe we
can potentially exploit the use of the gradient factor to deter-
mine where plan perturbations are least disruptive for adaptive
planning scenarios. Adaptive therapy based on physiological
response to therapy is by definition based on a pattern of re-
sponse of target and normal tissue to the original dose distri-
bution. Thus, we believe that the best adaptive plan is one that
will make only the minimal perturbations required to the orig-
inal dose distribution to achieve the adaptive plan goals but,
at the same time, not alter confidence in relying on the dose
response relationships that already have been established via
during-treatment feedback data and imaging relative to origi-
nal treatment plans.
Other secondary tasks include improving the overall op-
timization efficiency and code implementation for hybrid
IMRT/VMAT planning, including an investigation on the use
of graphics processing units (GPU) for optimization. Addi-
tionally, while FusionArc plans could be delivered currently
as two separate components—a single arc with standard step-
and-shoot IMRT segments—the optimal delivery mode for
hybrid plans should be determined, with the potential of co-
development efforts with vendors to implement a new deliv-
ery mode for FusionArc which allows IMRT control points
(with no gantry change) within a VMAT control point se-
quence (with gantry changes). Furthermore, a study of con-
verting multiple beams at a time to fluence is warranted to
determine when this decrease in planning and optimization
time may be worth small potential increases in final cost.
FIG. 12. Dose volume histograms for a brain patient with seven beam IMRT, VMAT, three beam hybrid FusionArc, and five beam hybrid FusionArc plans.
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V. CONCLUSIONS
FusionArc, a hybrid VMAT/IMRT inverse planning strat-
egy, was designed and implemented to allow the simultane-
ous optimization of VMAT apertures and IMRT beams for
dosimetric quality and delivery efficiency without switch-
ing between delivery techniques. As part of the optimization
strategy, a gradient factor calculation was developed, vali-
dated, and implemented. We have demonstrated that the gra-
dient factor accurately predicts the beams that will increase
plan quality the most upon conversion to fluence. In the cur-
rent work, the gradient factor was used to select one to five
beam angles to convert to fluence for the creation of multi-
ple FusionArc plans. Our results point to the fact that there
are distinct trade-offs between efficiency and quality as in-
creasing amounts of modulation are applied to the baseline
single-arc VMAT plan. The ideal number of IMRT beams in
FusionArc plans will likely vary as more clinical sites are
studied. Further work will investigate the possibilities sug-
gested by these results.
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